A look at the Factors Affecting the Commercialization of Products in Iranian Medical Biotechnology Accelerators

Document Type : Original Research

Authors

1 TEHRAN UNIVERSITY

2 Pasteur Institute

3 Tehran university

Abstract
This study investigates the factors affecting the commercialization of products in medical biotechnology accelerators, it also demonstrates the priority of these factors. The research is applied and descriptive survey. It has been done in two phases, qualitative and quantitative. Based on the general purpose of this study, to provide a framework for the commercialization of products in medical biotechnology accelerators, we interviewed with informed experts. 62 sub-codes were obtained as effective factors in the commercialization of products in medical biotechnology accelerators, which were classified into 5 main dimensions including individual, organizational, industry and competition, institutional and product. These dimensions are presented as a framework. In the quantitative phase, the main dimensions as well as the sub-themes were ranked in the main dimension. Finally, the priority of the main dimensions was as follows: 1. Individual (personality, behavioral and mental characteristics of the mentor and manager) 2. Industry and competition (interaction with pharmaceutical companies as customers, investors, etc.) 3. Organizational (experience of startup teams, codified strategy, R&D, etc.) 4. Product (value added and high-tech) 5. Institutional (government is pragmatic to the country's slogans, interaction with government managers, etc.).

Keywords

Subjects


Adkins, Dinah. (2011, June). “What are the New Seed or Venture Accelerators?”
NBIA Review. Retrieved June 5, 2014 from
http://www.nbia.org/resource_library/review_archive/0611_01.php.
Bianchi, M; Frattini, F; Lejarraga, J and Di Minin, A . (2014). Technology
Exploitation Paths: Combining Technological and Complementary Resources in
New Product Development and Licensing. J PROD INNOV MANAG.
31(S1):146–169
Braun., V. Clarke., V. (2006). Using Theramatic Analysis in Psychology. Qualitive
Research in Psychology. 3 (2). 77-101
Crossan, M and Apaydin, M . (2010). A Multi-Dimensional Framework of
Organizational Innovation: A Systematic Review of the Literature. Journal of
Management Studies 47:6, 1154-1191
Dian, A. (2004). S&T Commercialization of Fedral Research Laborites and
University Research. Caleton University Eric Sport, School of Business,Canada.
Ernst, H and Fischer, M . (2014). Integrating the R&D and Patent Functions:
Implications for New Product Performance. J PROD INNOV MANAG. 31(S1), 1-
15
Fereidoun Mahboudi , Haleh Hamedifar and Hamideh Aghajani . (2012). Medical
Biotechnology Trends and Achievements in Iran. Avicenna J Med Biotechnol.
4(4): 200–205.
Fishback, Bo, Christine Gulbranson, Robert Litan, Lesa Mitchell, and Marisa
Porzig. (2007). “Finding Business ‘Idols’: A New Model to Accelerate Startups.”
Ewing Marion Kauffman Foundation, Kansas City, MO
Fári MG, Kralovánszky UP. The founding father of biotechnology: Károly (Karl)
Ereky. Int J Hortic Sci. 2006;12(1):9–12. [Google Scholar]
Fowle, M (2017). Critical Success Factors for Business Accelerators: A
Theoretical Context. https://www.researchgate.net/publication/320183467
Ferguson, G. (2008), Commercialisation Models. Unpublished. Available online at
http://www.rumourcontrol.com.au/analysis/commercialisatio n_models.pdf; [5] G.,
Banusanu, F.,
Godin, B. (2006). Research and development: how the ‘D’ got into R&D. Science
and Public Policy, 33 (1), 59–76
Hoffman, David L., and Nina Radojevich-Kelley. (2012). “Analysis of Accelerator
Companies: An Exploratory Case Study of Their Programs, Processes, and Early
Results.” Small Business Institute Journal, 8.2, 54-70.
Hallen, B. L., Bingham, C. B., & Cohen, S. (2014b). Do accelerators accelerate? A
study of venture accelerators as a path to success? Academy of Management
Proceedings, 2014, 12955. Retrieved from
http://proceedings.aom.org/content/2014/1/12955.short
Hochberg, Y. V. (2016). Accelerating Entrepreneurs and Ecosystems: The Seed
Accelerator Model. Innovation Policy and the Economy, 16(1), 25–51.
https://doi.org/10.1086/684985
Kim, N., Min, S. and Chaiy, S. (2015), “Why do firms enter a new product market?
A two-dimensional framework for market entry motivation and behavior”, Journal
of Product Innovation Management, Vol. 32 No. 2, pp. 263-278.
Isabelle, Diane. (2013, February). “Key Factors Affecting a Technology
Entrepreneur’s Choice of Incubator or Accelerator.” Technology Innovation
Management Review. Retrieved August 11, 2014 from
http://timreview.ca/article/656.
Jed D. Christiansen.(2009, August). COPYING Y COMBINATOR, A framework
for developing Seed Accelerator Programmes. MBA Dissertation / Individual
Project .Judge Business School & Jesus College, Cambridge.University of
Cambridge.
Kohen, S. (2013). What Do Accelerators Do? Insights from Incubators and Angels.
innovations / volume 8, number ¾
Kohler, T. (2016). Corporate accelerators: Building bridges between corporations
and startups. Business Horizons, 59(3), 347–357.
https://doi.org/10.1016/j.bushor.2016.01.008
from six European Universities. International Entrepreneurship and Management
Journal. 2(2), 173-187
Mason, C., & Brown, R. (2014). Entrepreneurial ecosystems and growth oriented
entrepreneurship. Final Report to OECD, Paris. Retrieved from
http://lib.davender.com/wp-content/uploads/2015/03/Entrepreneurial-ecosystems
OECD.pdf
Sasson A. (2006). Medical biotechnology: achievements, prospects and
preception. Tokyo, New York, Paris: United Nations University press.